Stability Studies for Medicinal Cannabis
Launching or importing medicinal cannabis in Germany requires absolute regulatory compliance. Alphalytik Pharmaservice offers fully validated GMP ongoing stability studies in high-security facilities, providing the audit-ready shelf-life data required by the BfArM and local German health authorities.
Navigating the German Regulatory Framework
Pharmacopoeia Compliance: All studies are designed to meet the strict criteria of the European Pharmacopoeia (Ph. Eur.) cannabis flower monographs and the German Pharmacopoeia (DAB) cannabis extract specifications.
GMP & FDA Approved: Our facilities and processes adhere to the highest regulatory standards, ensuring your products meet global compliance requirements.
Industry-Leading Expertise: Our team of highly skilled analytical scientists brings deep knowledge across a vast array of pharmaceutical and biotechnological products.
Narcotics & MedCanG Licensing: Our high-security facility satisfies all German regulatory prerequisites for storing and handling controlled medical plant material.
Our Comprehensive Stability Study Services:
Alphalytik offers a full spectrum of ICH conditions and analytical testing services to ensure your products are safe, pure, potent, and compliant over their lifetime:
Full Analytical Testing
Pharmaceutical-grade medicinal cannabis analysis requires a comprehensive suite of testing encompassing precise cannabinoid potency profiling, terpene analysis, water loss, and rigorous safety screenings for microbials, and residual solvents to ensure compliance.
Advanced ICH Storage for Cannabis
Our state-of-the-art ICH climate chambers (as utilized across our premium pharmaceutical services) are meticulously qualified to protect the delicate terpene and cannabinoid profiles of your product under all ICH conditions.
Cannabis Batch Release
Alphalytik delivers comprehensive, GMP-compliant batch release analytics according to Ph. Eur. , providing the precise data required for release certification. Our testing pipeline ensures rapid market entry and undisrupted supply chains for medicinal cannabis in Germany and Europe.
The Alphalytik Advantage:
Accelerated Timelines:
Our efficient processes and dedicated project management minimize turnaround times without compromising accuracy.
Reduced Risk:
Mitigate regulatory risks and avoid costly delays with our meticulous approach and robust quality systems.
Unwavering Quality:
A commitment to data integrity, precision, and adherence to the highest scientific standards.
Dedicated Project Management:
A single point of contact ensures clear communication, transparency, and a smooth project flow from start to finish.
Global Regulatory Support:
Expertise in navigating diverse regulatory landscapes to ensure your products can reach markets worldwide.